Clinical significance of HIV-1 coreceptor usage
2011

Understanding HIV-1 Coreceptor Usage

publication Evidence: moderate

Author Information

Author(s): Hanneke Schuitemaker, Angélique van 't Wout, Paolo Lusso

Primary Institution: Academic Medical Center of the University of Amsterdam

Hypothesis

What is the clinical significance of HIV-1 coreceptor usage in disease progression and treatment outcomes?

Conclusion

The study highlights the importance of HIV-1 coreceptor usage in understanding disease progression and treatment responses.

Supporting Evidence

  • HIV-1 uses CCR5 and CXCR4 as coreceptors to enter cells.
  • Different HIV-1 variants can affect disease progression and treatment outcomes.
  • The presence of CXCR4-using variants is associated with faster disease progression.

Takeaway

HIV-1 uses different doorways to enter cells, and knowing which door it uses can help doctors treat the infection better.

Methodology

The review summarizes findings from various studies on HIV-1 coreceptor usage and its implications.

Limitations

The review is based on existing literature and may not cover all recent developments in the field.

Digital Object Identifier (DOI)

10.1186/1479-5876-9-S1-S5

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication